1. Migration and infectious diseases
F. Castelli, G. Sulis 
Clinical Microbiology and Infection 
Volume 23, Issue 5, Pages (May 2017)
DOI: /j.cmi
Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

2. Fig. 1
Estimated coverage rates for MCV1, HepB3 and DTP3 in the top three countries of origin for refugees and asylum seekers in Such estimates are based on a combination of official government information, administrative coverage data and periodic surveys and refer to the paediatric population aged 12–23 months (Source: WHO/UNICEF, Abbreviations: MCV1, measles-containing vaccine first dose; HepB3, hepatitis B third dose; DTP3, diphtheria/ tetanus/ pertussis third dose.
Clinical Microbiology and Infection  , DOI: ( /j.cmi )
Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

3. Fig. 2
Proportion of new human immunodeficiency virus (HIV) infections diagnosed among native and foreign-born individuals in five of the eight European countries with the largest migrant population, in Note: data from Kazakhstan, Russian Federation and Ukraine were not available. (Source: ECDC 2015,
Clinical Microbiology and Infection  , DOI: ( /j.cmi )
Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

4. Fig. 3
Proportion of tuberculosis (TB) cases diagnosed among foreign-born individuals in the top-five EU countries with the largest migrant populations. *Data from France, Germany, Spain and the UK refer to 2014, data from Italy refer to (Source: ECDC
Clinical Microbiology and Infection  , DOI: ( /j.cmi )
Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions